Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Language
Publication year range
1.
Brain Behav Immun ; 97: 22-31, 2021 10.
Article in English | MEDLINE | ID: mdl-34022373

ABSTRACT

Inappropriate synaptic development has been proposed as a potential mechanism of neurodevelopmental disorders, including attention-deficit hyperactivity disorder (ADHD). Major histocompatibility complex class I (MHCI), an immunity-associated molecule expressed by neurons in the brain, regulates synaptic development; however, the involvement of MHCI in these disorders remains elusive. We evaluated whether functional MHCI deficiency induced by ß2m-/-Tap1-/- double-knockout in mice leads to abnormalities akin to those seen in neurodevelopmental disorders. We found that functional MHCI deficiency induced locomotor hyperactivity, motor impulsivity, and attention deficits, three major symptoms of ADHD. In contrast, these mice showed normal spatial learning, behavioral flexibility, social behavior, and sensorimotor integration. In the analysis of the dopamine system, upregulation of dopamine D1 receptor (D1R) expression in the nucleus accumbens and a greater locomotor response to D1R agonist SKF 81297 were found in the functional MHCI-deficient mice. Low-dose methylphenidate, used for the treatment of ADHD patients, alleviated the three behavioral symptoms and suppressed c-Fos expression in the D1R-expressing medium spiny neurons of the mice. These findings reveal an unexpected role of MHCI in three major symptoms of ADHD and may provide a novel landmark in the pathogenesis of ADHD.


Subject(s)
Attention Deficit Disorder with Hyperactivity , Genes, MHC Class I , Methylphenidate , Receptors, Dopamine D1 , Animals , Attention Deficit Disorder with Hyperactivity/genetics , Dopamine , Humans , Mice , Receptors, Dopamine D1/genetics , Social Behavior
2.
Sci Adv ; 4(3): eaap7388, 2018 03.
Article in English | MEDLINE | ID: mdl-29546241

ABSTRACT

Major histocompatibility complex class I (MHCI) is an important immune protein that is expressed in various brain regions, with its deficiency leading to extensive synaptic transmission that results in learning and memory deficits. Although MHCI is highly expressed in dopaminergic neurons, its role in these neurons has not been examined. We show that MHCI expressed in dopaminergic neurons plays a key role in suppressing reward-seeking behavior. In wild-type mice, cocaine self-administration caused persistent reduction of MHCI specifically in dopaminergic neurons, which was accompanied by enhanced glutamatergic synaptic transmission and relapse to cocaine seeking. Functional MHCI knockout promoted this addictive phenotype for cocaine and a natural reward, namely, sucrose. In contrast, wild-type mice overexpressing a major MHCI gene (H2D) in dopaminergic neurons showed suppressed cocaine seeking. These results show that persistent cocaine-induced reduction of MHCI in dopaminergic neurons is necessary for relapse to cocaine seeking.


Subject(s)
Behavior, Animal , Dopaminergic Neurons/metabolism , Histocompatibility Antigens Class I/metabolism , Reward , Animals , Cocaine/administration & dosage , Extinction, Psychological , Glutamates/metabolism , Mice, Inbred C57BL , Mice, Knockout , Self Administration , Sucrose/administration & dosage , Synaptic Transmission , Ventral Tegmental Area/metabolism
4.
PLoS One ; 9(9): e107099, 2014.
Article in English | MEDLINE | ID: mdl-25268136

ABSTRACT

Major histocompatibility complex class I (MHCI) molecules were recently identified as novel regulators of synaptic plasticity. These molecules are expressed in various brain areas, especially in regions undergoing activity-dependent synaptic plasticity, but their role in the nucleus accumbens (NAc) is unknown. In this study, we investigated the effects of genetic disruption of MHCI function, through deletion of ß2-microblobulin, which causes lack of cell surface expression of MHCI. First, we confirmed that MHCI molecules are expressed in the NAc core in wild-type mice. Second, we performed electrophysiological recordings with NAc core slices from wild-type and ß2-microglobulin knock-out mice lacking cell surface expression of MHCI. We found that low frequency stimulation induced long-term depression in wild-type but not knock-out mice, whereas high frequency stimulation induced long-term potentiation in both genotypes, with a larger magnitude in knock-out mice. Furthermore, we demonstrated that knock-out mice showed more persistent behavioral sensitization to cocaine, which is a NAc-related behavior. Using this model, we analyzed the density of total AMPA receptors and their subunits GluR1 and GluR2 in the NAc core, by SDS-digested freeze-fracture replica labeling. After repeated cocaine exposure, the density of GluR1 was increased, but there was no change in total AMPA receptors and GluR2 levels in wild-type mice. In contrast, following repeated cocaine exposure, increased densities of total AMPA receptors, GluR1 and GluR2 were observed in knock-out mice. These results indicate that functional deficiency of MHCI enhances synaptic potentiation, induced by electrical and pharmacological stimulation.


Subject(s)
Histocompatibility Antigens Class I/genetics , Nucleus Accumbens/physiopathology , Animals , Excitatory Postsynaptic Potentials , Histocompatibility Antigens Class I/metabolism , Long-Term Potentiation , Long-Term Synaptic Depression , Male , Mice, Inbred C57BL , Mice, Knockout , Neuronal Plasticity , Nucleus Accumbens/metabolism , Receptors, AMPA/metabolism
5.
Expert Opin Drug Metab Toxicol ; 6(12): 1461-75, 2010 Dec.
Article in English | MEDLINE | ID: mdl-21067457

ABSTRACT

IMPORTANCE OF THE FIELD: cardiac arrhythmia represents one of the primary safety pharmacological concerns in drug development. The most prominent example is drug induced ventricular tachycardia of the Torsade des Pointes type. The mechanism how this type of arrhythmia develops is a complex multi-cellular phenomenon. It can only be insufficiently reflected by cellular or molecular assays. However, organ models - such as Langendorff hearts - or in vivo experiments are expensive and time consuming and not suitable for assays requiring an increased throughput. AREAS COVERED IN THIS REVIEW: here, we describe and review an assay bridging the gap between cardiomyocyte based assays and organ based systems - cardiac slices. This assay is reviewed in direct comparison with established safety pharmacological assays. WHAT THE READER WILL GAIN: while slices have played an important role in brain research for > 2 decades, cardiac slices are experiencing a renaissance due to the novel challenges in safety pharmacology just in the last few years. Cardiac slices can be cultured and recorded over several days. It is possible to access electrophysiological data with a high number of electrodes - up to 256 electrodes - embedded in the surface of a microelectrode array. TAKE HOME MESSAGE: cardiac slices close the gap between cellular and organ based assays in cardiac safety pharmacology. The tissue properties of a functional cardiac syncytium are more accurately reflected by a slice rather than a single cell.


Subject(s)
Arrhythmias, Cardiac/chemically induced , Drug-Related Side Effects and Adverse Reactions , Models, Biological , Animals , Drug Design , Electrophysiologic Techniques, Cardiac/methods , Heart/drug effects , Humans , Microelectrodes , Myocytes, Cardiac/drug effects , Myocytes, Cardiac/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...